Skip to main content

Table 2 The 3-and 5-year overall survival and cancer-specific survival in terms of patient characteristics

From: Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma

Variables Overall Survival Cancer-Specific Survival
3-year (%) 5-year (%) 3-year (%) 5-year (%)
Age, years
 < 50 73.4 66.3 74.4 67.8
 50–60 82.0 73.7 82.9 75.3
 > 60 76.4 70.2 78.6 73.4
Tumor size, cm
 ≤ 12 77.4 72.8 79.0 75.0
 > 12 78.4 68.4 79.6 70.4
Race
 White 79.2 72.5 80.7 74.8
 Black 57.7 40.3 61.3 42.8
 Other 76.8 68.8 77.4 70.0
Laterality
 Unilateral 81.8 75.1 83.1 77.2
 Bilateral 46.4 35.5 48.4 37.1
AJCC Stage (7th)
 I 91.2 85.6 92.2 87.2
 II 76.9 74.5 78.3
 III 46.7 34.1 49.0 35.8
 IV 40.8 27.9 41.7 30.5
Grade
 I/II 85.4 73.6 86.3 79.2
 III 75.9 67.4 77.0 69.2
 IV 78.5 75.0 80.9 77.3
 Unknown
LN dissected, n
 No 64.1 59.7 66.7 63.3
 1–10 78.4 70.6 79.6 72.7
 > 10 83.1 75.1 84.2 76.6
LN
 No dissection or Negative 78.5 70.7 79.9 72.6
 Positive 72.5 69.8 74.3 70.1
Organ Metastasis
 No 79.0 71.8 80.5 73.9
 Yes 30.5 22.2 30.5 26.7
Radiotherapy
 No/Unknown 78.0 70.7 79.5 72.9
 Yes 66.4 33.2 66.4
Chemotherapy
 No/Unknown 80.5 76.1 83.4 80.5
 Yes 77.2 69.4 78.4 71.1
  1. AJCC American Joint Committee on Cancer, LN lymph node